As a global genetic sequencer giant, Mena continues to deepen its local manufacturing and delivery capabilities in the Chinese market. On November 6, Inmena held the “MiSeq™ i100 Series-CN Local Manufacturing and Customer Delivery Milestone Event” at the CIIE site. Since it was officially launched in China in August this year, the first batch of products produced at the Chinese manufacturing base has been delivered to customers. According to Mena, MiSeq™ i100 Series-CN supports the expanding sequencing application needs of Chinese customers in the fields of scientific research, public health, and biomedicine with uniform global quality standards and product supply and service responses closer to the local market. More than 20 MiSeq™ i100 Series-CN are expected to be delivered by the end of this year.

As a global genetic sequencer giant, Mena continues to deepen its local manufacturing and delivery capabilities in the Chinese market. On November 6, Inmena held the “MiSeq™ i100 Series-CN Local Manufacturing and Customer Delivery Milestone Event” at the CIIE site. Since it was officially launched in China in August this year, the first batch of products produced at the Chinese manufacturing base has been delivered to customers. According to Mena, MiSeq™ i100 Series-CN supports the expanding sequencing application needs of Chinese customers in the fields of scientific research, public health, and biomedicine with uniform global quality standards and product supply and service responses closer to the local market. More than 20 MiSeq™ i100 Series-CN are expected to be delivered by the end of this year.